Insider buying last 90 days
No open-market insider purchases were filed for UHS in the last 90 days.
From Form 4 filings, dated to when each was filed.
Nov 13 close
Universal Health Services reported third-quarter results with net revenues rising 5.3% to $4.733 billion, while net income fell 17% to $308.684 million and diluted earnings per share declined to $5.22 from $5.86, a drop attributed in part to a $26 million increase in liability reserves tied to its Cumberland Hospital subsidiary. The quarter also reflected Medicaid supplemental program benefits offset by litigation and transaction costs, alongside sequential improvement in acute care demand and behavioral health volumes. Separately, shares were noted trading higher alongside healthcare peers following election results confirming Democratic majorities in the House and Senate, and options traders have drawn attention for recent unusual activity in the stock.
UHS closed at $197.16, up 0.8%, sitting above both its 50-day average of $179.14 and 200-day average of $176.62, with the 50-day above the 200-day. The GekkoIndex reads 48.1, placing the stock in the Neutral zone, down from a five-day change of -11.2. Price stands 13.5% below Gekko Fair Value of $227.99.
The next earnings date falls on 24 February 2027, outside a typical 20-trading-day holding window. Over the last 30 days, 2 unusual options signals were recorded, with put premium of $1,234,716 against call premium of $72,610. Seasonality over five years shows a 2.3% average 20-day return from this point, rising in 2 of those years. Analyst consensus among 14 firms stands at 4 buy, 9 hold, 1 sell, with a consensus target of $192.41.
Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.
Universal Health Services scores 3 supportive, 2 mixed and 1 headwind across the 6 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive2 mixed1 headwind
Above 50 and 200-day
Close $194.07 is above the 50-day ($181.19) and 200-day ($176.46) averages, and the 50-day is above the 200-day.
See the chart52.3, Neutral
Reading 52.3 is in the Neutral zone.
See the GekkoIndex11.5% below
Price is 11.5% below Gekko Fair Value (more than 5% below).
See fair valueLeans bearish
Last 30 days: 2 unusual options signals.
See smart moneyReports in 101 days
Next report Feb 24, 2027, 101 days away — outside a typical 20-trading-day hold.
See earnings+1.3% on average
From this point in the calendar, the next 20 trading days averaged +1.3% over 5 years, rising in 2 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Universal Health Services closed at $194.07 on Nov 13, 2026, −15.0% over the past year, inside a 52-week range of $140.08 to $246.33.
Use the left and right arrow keys to read daily values.
Put UHS on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Universal Health Services operates hospitals and treatment sites that deliver a wide array of medical care, including surgery, emergency and urgent treatment, cancer therapy, heart care, children's medicine, obstetrics and mental health support. It is known for combining general hospital care with a large presence in behavioral health treatment.
The company organizes its work into two segments, one covering acute care hospitals and the other focused on behavioral health. In addition to treating patients, it sells commercial health insurance and supplies internal services to its facilities such as purchasing, technology systems, financial management, planning for new sites, hiring doctors, staffing support, and marketing and communications.
Universal Health Services traces back to 1978 and runs its main offices from King of Prussia, Pennsylvania. Its hospitals and centers are located throughout much of the United States as well as in the District of Columbia, the United Kingdom and Puerto Rico. Shares trade on the NYSE under the ticker UHS.
Universal Health Services’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 52.3, in the Neutral zone, up 4.2 points over five sessions.
Up 4.2 points over five sessions.
Reading for Nov 13, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 46 | +1.0% | +4.1% | ||
| Accumulation | 240 | +0.1% | −0.2% | ||
| Neutral (current zone) | 373 | +0.3% | +0.8% | ||
| Distribution | 42 | +0.1% | +2.9% | ||
| Selling | 1 | Too few readings yet | |||
Average UHS share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +0.9% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
Universal Health Services trades 11.5% below Gekko Fair Value of $219.37, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Universal Health Services shares are worth, recalculated every trading day.
$219.37
Gekko Fair Value, Nov 14, 2026
11.5% Undervalued
At the end of Aug 2026 the price was 29.2% below the estimate.
No open-market insider purchases were filed for Universal Health Services, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for UHS in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in UHS were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Universal Health Services has been buying back its own shares.
From company filings.
2signals, 6% of the flagged premium in calls.
Latest: Bearish flow on Oct 28, $969K in unusual premium.
1of the funds Gekko tracks holds UHS.
Universal Health Services reports on Feb 24, 2027, after the close (101 days away), and beat the EPS estimate in 7 of its last 8 reports.
Feb 24, 2027
Expected after the close, 101 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Oct 27, 2026 | $5.22 est $5.19 | $4.73B est $4.71B | −7.3% |
| Jul 27, 2026 | $5.98 est $5.66 | $4.64B est $4.58B | +6.7% |
| Apr 27, 2026 | $5.62 est $5.29 | $4.50B est $4.39B | −6.8% |
| Feb 25, 2026 | $5.88 est $5.92 | $4.49B est $4.50B | −11.2% |
| Oct 27, 2025 | $5.69 est $4.66 | $4.50B est $4.50B | +4.1% |
| Jul 28, 2025 | $5.35 est $4.92 | $4.28B est $4.24B | +4.6% |
| Apr 28, 2025 | $4.84 est $4.35 | $4.10B est $4.15B | +0.1% |
| Feb 26, 2025 | $4.92 est $4.21 | $4.11B est $4.01B | −1.6% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Universal Health Services is $195.24, +0.6% from the last close, from 15 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 15 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Nov 11 | Mizuho Securities | $225 | +15.9% |
| Nov 10 | RBC Capital | $207 | +6.7% |
| Nov 9 | Goldman Sachs | $190 | −2.1% |
| Nov 5 | Bank of America Securities | — | — |
| Nov 2 | Wells Fargo | $170 | −12.4% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Nov 14, Universal Health Services averaged +1.3% across the last 5 years, rising in 2 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +0.7% | 3 of 5 |
| Next 10 trading days | +1.1% | 4 of 5 |
| Next 15 trading days | +0.2% | 3 of 5 |
| Next 20 trading days | +1.3% | 2 of 5 |
| Next 30 trading days | +3.4% | 3 of 5 |
For scale, UHS’s typical 20-trading-day move in either direction is about 6.8%.
Universal Health Services’s market cap is $9.78B, with a P/E ratio of 8.1 and revenue of $18.35B over the last twelve months.
Coverage of Universal Health Services this week reads neutral: 1 positive, 1 neutral and 1 negative headlines.
Universal Health Services’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| HCAHCA Healthcare | Neutral | 26.1% above |
| THCTenet Healthcare | Neutral | 3.0% below |
| PACSPACS | Neutral | 6.5% below |
| CHEChemed | Neutral | 2.8% below |
| SGRYSurgery Partners | Distribution | 45.2% above |
| NHCNational HealthCare | Accumulation | 18.9% above |
A peer links to its own page where one exists.
Universal Health Services’s market cap is $9.78B at the Nov 13, 2026 close of $194.07, with 50.40M shares outstanding. The shares trade on a P/E ratio of 8.1.
The consensus analyst 12-month price target for Universal Health Services is $195.24, +0.6% from the last close. Of the 15 firms that rated the stock in the last 90 days, 5 rate it a buy, 9 a hold and 1 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Universal Health Services is undervalued: the Nov 13, 2026 close of $194.07 is 11.5% below Gekko Fair Value of $219.37. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Universal Health Services is expected to report on Feb 24, 2027, after the market closes (101 days away). Analysts expect earnings of $5.63 per share on revenue of $4.75B. Universal Health Services beat the earnings estimate in 7 of its last 8 reports, moving 5.3% on average across the report.
Universal Health Services’s 52-week high is $246.33 and its 52-week low is $140.08; it closed at $194.07 on Nov 13, 2026, −15.0% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 6 items with data read as supportive (trend, fair value and earnings risk), 2 as mixed (gekkoindex and seasonality) and 1 as a headwind (smart money). The checklist is a description of current data, not a recommendation.
Gekko flagged 2 unusual options signals in Universal Health Services over the last 30 days, with $73K of flagged premium in calls and $1.23M in puts. The latest, bearish flow, was on Oct 28, 2026 with $969K in unusual premium. The signal-by-signal table is in Gekko.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,475 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.